Teriparatide as a Regenerative Therapy in Knee OsteoarthritisResearch Question:
Does the medication Teriparatide help with osteoarthritis of the knee?
Basic Study Information
Purpose:Location: URMC Orthopaedics, Clinton Crossings Building D
If you decide to take part in this study, you will be asked to complete UP TO 16 study
visits over the course of the next two and a half years. This study will determine
if the drug Teriparatide (Forteo)improves arthritis in knee joints. If you have osteoarthritis
in your knee you may be eligible to enroll.
You will be assigned by chance (like flipping a coin) to one of two groups. Group
1 will receive the study drug (teriparatide) and Group 2 will receive a placebo (saline).
There is an equal chance that you will be assigned to either group. Study Staff members
will not know which group you have been assigned to.
You will be asked to inject yourself with the study injection pen every day for 24
weeks. A nurse will teach you how to administer the injection.
As a part of these visits study staff will ask you to rate your pain and test your
physical function. They will also collect height, weight, blood pressure, pulse, collect
blood and urine samples and pain surveys. You will have x rays and MRIs of your knee.
Study Reference #: NA6
Lead Researcher (Principal Investigator)
Lead Researcher: Christopher Ritchlin
Study Contact InformationStudy Coordinator: Samantha Hoffman
Phone: (585) 341-9056
Additional Study Details
Number of Visits:
6 to 10
Trial Not Found
The study you are looking for is not active at this time.
Return to Search